Development of anti-cancer therapeutics has been traditionally reliant on two-dimensional (2D) systems and animal models, both of which have major limitations that contribute to the poor clinical translation of preclinical findings. The goal of this thesis work was to develop three-dimensional (3D) in vitro models of bone malignancies for accurate drug testing and mechanistic studies. To this end, I investigated the use of different 3D scaffolds to recreate the distinct in vivo bone niches relevant for these bone cancers in vitro. First, I evaluated the use of electrospun poly(ε-caprolactone) scaffolds to provide 3D architectural cues for the culture of Ewing sarcoma (EWS) cells. 3D-cultured EWS cells were remarkably different from the same...
The lack of effective therapies for bone metastatic prostate cancer (PCa) underscores the need for a...
Breast cancer in its advanced stage has a high predilection to the skeleton. Currently, treatment op...
In this study we developed and validated a 3D-printed drug delivery system (3DPDDS) to 1) improve lo...
Development of anti-cancer therapeutics has been traditionally reliant on two-dimensional (2D) syste...
In the cancer research field, most in vitro studies still rely on two-dimensional (2D) cultures. How...
Preclinical drug testing commonly relies on the use of two-dimensional (2D) cultures, which allow fo...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
Osteosarcoma is a primary bone tumor characterized by a dismal prognosis, especially in the case of ...
The complex nature of cancer metastasis necessitates the development of a cancer model based on spec...
The lack of traditional cancer treatments has resulted in an increased need for new clinical techniq...
We produced a novel three-dimensional (3D) bone tumor model (BTM) to study the interactions between ...
The lack of effective therapies for bone metastatic prostate cancer (PCa) underscores the need for a...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
The lack of effective therapies for bone metastatic prostate cancer (PCa) underscores the need for a...
Breast cancer in its advanced stage has a high predilection to the skeleton. Currently, treatment op...
In this study we developed and validated a 3D-printed drug delivery system (3DPDDS) to 1) improve lo...
Development of anti-cancer therapeutics has been traditionally reliant on two-dimensional (2D) syste...
In the cancer research field, most in vitro studies still rely on two-dimensional (2D) cultures. How...
Preclinical drug testing commonly relies on the use of two-dimensional (2D) cultures, which allow fo...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
Osteosarcoma is a primary bone tumor characterized by a dismal prognosis, especially in the case of ...
The complex nature of cancer metastasis necessitates the development of a cancer model based on spec...
The lack of traditional cancer treatments has resulted in an increased need for new clinical techniq...
We produced a novel three-dimensional (3D) bone tumor model (BTM) to study the interactions between ...
The lack of effective therapies for bone metastatic prostate cancer (PCa) underscores the need for a...
Patient-derived xenograft (PDX) models better represent human cancer than traditional cell lines. Ho...
The lack of effective therapies for bone metastatic prostate cancer (PCa) underscores the need for a...
Breast cancer in its advanced stage has a high predilection to the skeleton. Currently, treatment op...
In this study we developed and validated a 3D-printed drug delivery system (3DPDDS) to 1) improve lo...